413 related articles for article (PubMed ID: 30385329)
1. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.
Sugita S; Kawazoe Y; Imai A; Yamada Y; Horie S; Mochizuki M
Arthritis Res Ther; 2012 May; 14(3):R99. PubMed ID: 22546542
[TBL] [Abstract][Full Text] [Related]
3. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-26 is overexpressed in Behçet's disease and enhances Th17 related -cytokines.
Kaabachi W; Bouali E; Berraïes A; Dhifallh IB; Hamdi B; Hamzaoui K; Hamzaoui A
Immunol Lett; 2017 Oct; 190():177-184. PubMed ID: 28811236
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
Na SY; Park MJ; Park S; Lee ES
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):32-40. PubMed ID: 24064012
[TBL] [Abstract][Full Text] [Related]
6. IFN-α induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease.
Touzot M; Cacoub P; Bodaghi B; Soumelis V; Saadoun D
Autoimmun Rev; 2015 May; 14(5):370-5. PubMed ID: 25541082
[TBL] [Abstract][Full Text] [Related]
7. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.
Shimizu J; Takai K; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Suzuki N
Clin Exp Immunol; 2012 Apr; 168(1):68-74. PubMed ID: 22385240
[TBL] [Abstract][Full Text] [Related]
8. Effect of Interferon alfa-2a Treatment on Adaptive and Innate Immune Systems in Patients With Behçet Disease Uveitis.
Albayrak O; Oray M; Can F; Uludag Kirimli G; Gul A; Tugal-Tutkun I; Onal S
Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):52-63. PubMed ID: 30601931
[TBL] [Abstract][Full Text] [Related]
9. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease.
Ahmadi M; Yousefi M; Abbaspour-Aghdam S; Dolati S; Aghebati-Maleki L; Eghbal-Fard S; Khabbazi A; Rostamzadeh D; Alipour S; Shabani M; Nouri M; Babaloo Z
J Cell Physiol; 2019 Apr; 234(4):3985-3994. PubMed ID: 30317557
[TBL] [Abstract][Full Text] [Related]
10. A possible role for interleukin 37 in the pathogenesis of Behcet's disease.
Ye Z; Wang C; Kijlstra A; Zhou X; Yang P
Curr Mol Med; 2014 May; 14(4):535-42. PubMed ID: 24730521
[TBL] [Abstract][Full Text] [Related]
11. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease.
Aktas Cetin E; Cosan F; Cefle A; Deniz G
Mod Rheumatol; 2014 Sep; 24(5):802-7. PubMed ID: 24498963
[TBL] [Abstract][Full Text] [Related]
12. Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease.
Lopalco G; Lucherini OM; Vitale A; Talarico R; Lopalco A; Galeazzi M; Lapadula G; Cantarini L; Iannone F
Medicine (Baltimore); 2015 Oct; 94(42):e1858. PubMed ID: 26496336
[TBL] [Abstract][Full Text] [Related]
13. Possible association of proinflammatory cytokines including IL1β and TNFα with enhanced Th17 cell differentiation in patients with Behcet's disease.
Shimizu J; Takai K; Takada E; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Suzuki T; Suzuki N
Clin Rheumatol; 2016 Jul; 35(7):1857-63. PubMed ID: 25972082
[TBL] [Abstract][Full Text] [Related]
14. An elevated pro-inflammatory cytokines profile in Behcet's disease: A multiplex analysis.
Gholijani N; Ataollahi MR; Samiei A; Aflaki E; Shenavandeh S; Kamali-Sarvestani E
Immunol Lett; 2017 Jun; 186():46-51. PubMed ID: 27939191
[TBL] [Abstract][Full Text] [Related]
15. Skewed TGFβ/Smad signalling pathway in T cells in patients with Behçet's disease.
Shimizu J; Izumi T; Arimitsu N; Fujiwara N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Takai K; Suzuki N
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S35-9. PubMed ID: 22935165
[TBL] [Abstract][Full Text] [Related]
16. Expression and function of inducible costimulator on peripheral blood CD4+ T cells in Behçet's patients with uveitis: a new activity marker?
Usui Y; Takeuchi M; Yamakawa N; Takeuchi A; Kezuka T; Ma J; Matsuda R; Okunuki Y; Akiba H; Goto H
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5099-104. PubMed ID: 20445113
[TBL] [Abstract][Full Text] [Related]
17. Decreased interleukin 27 expression is associated with active uveitis in Behçet's disease.
Wang C; Tian Y; Ye Z; Kijlstra A; Zhou Y; Yang P
Arthritis Res Ther; 2014 May; 16(3):R117. PubMed ID: 24887071
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation.
Bouali E; Kaabachi W; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Oct; 167(2):87-94. PubMed ID: 26253248
[TBL] [Abstract][Full Text] [Related]
19. Effect of 1,25-dihydroxyvitamin D3 on Th17 and Th1 response in patients with Behçet's disease.
Tian Y; Wang C; Ye Z; Xiao X; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6434-41. PubMed ID: 22918640
[TBL] [Abstract][Full Text] [Related]
20. Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes.
Song C; Hsu K; Yamen E; Yan W; Fock J; Witting PK; Geczy CL; Freedman SB
Atherosclerosis; 2009 Dec; 207(2):374-83. PubMed ID: 19535079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
